Margrethe Sørgaard offers 25 years’ experience in leading positions in clinical development and operation, medical affairs and drug safety/pharmacovigilance.
This webinar on May 1 will explore several alternative clinical supply models, use cases and identify key considerations when adopting one of these models.
This webinar on May 1 will explore several alternative clinical supply models, use cases and identify key considerations when adopting one of these models.
The collaboration aims to ensure the development of infigratinib for children living with achondroplasia, and eventually for other skeletal dysplasias in Japan.
Will create more than 150 new highly skilled jobs to focus on manufacturing T-cell therapies to enable clinical trials to be conducted around the world.